CAN LYVE-1 MOLECULE BE A DIAGNOSTIC BIOMARKER IN PATIENTS WITH ADVANCED LUNG CANCER?

Objective: Primary lung cancers that originate from epithelial cells are classified as carcinomas. Close monitoring of patients with predisposing conditions can enhance early diagnosis rates and facilitate the implementation of therapeutic approaches. LYVE-1 protein is localized to the lymphatic end...

Full description

Bibliographic Details

Published in:	Sabiad
Main Authors:	Murat Serilmez, Emre Özgür, Hilal Oğuz Soydinç, Ceren Tilgen Yasasever, Faruk Taş, Uğur Gezer, Derya Duranyıldız
Format:	Article
Language:	English
Published:	Istanbul University Press 2025-03-01
Subjects:	lyve-1 lung cancer lymphatic biomarker
Online Access:	https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/B916231CD3C54800AC40198A5AF93904